The Effect of Dexmedetomidine on renal colic

Phase 2

• Conditions: Renal colic.; Unspecified renal colic

• Registration Number: IRCT2015120625402N1
• Lead Sponsor: Ahvaz Jundishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Inclusion Criteria: typical physical complaints; a pain intensity between 3 to 10 on a 10 cm visual analogue scale (VAS) marked by the patient; a ureteric or kidney stone verified by ultrasonography and/or native abdominal X-ray; informed consent by the patient; and in women of fertile age, the apparent use of efficient contraception
Exclusion criteria: Age<18 y/o and age > 55y/o; Pain score < 3; Pian killer during 6 hours befor ED arrival; Addiction; Sensitivity to opioides or NSAIDs; Sensitivity to opioides or NSAIDs; SBP<90 mmHg; Abdominal tenderness and rebound; Body temperature>38 °C; History or documents suggesting cardiac, liver, respiratory or renal diseases; History of GIB or active GI ulcer; History of seizure; History of metabolic Disorder; Pregnancy; Suspicious abdominal aortic aneurism or dissection; Inability to speech

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration and intensity of pain in renal colic. Timepoint: Baseline. Method of measurement: visual analogue pain scale (VPAS).

Secondary Outcome Measures

Name	Time	Method
Decrease in duration and intensity of pain in renal colic. Timepoint: 20, 40, and 60 min after the first injection. Method of measurement: visual analogue pain scale (VPAS).